![Kevin Gillis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kevin Gillis
Finanzdirektor/CFO bei
Third Rock Ventures LLC
Profil
Mr. Kevin M.
Gillis is a Partner & Chief Operating Officer at Third Rock Ventures LLC.
Mr. Gillis was previously employed as a Vice President-Finance by Coley Pharmaceutical Group, Inc., a Principal by Millennium Pharmaceuticals, Inc., and a Principal by The Coca-Cola Co. He also served on the board at NinePoint Medical, Inc. and Warp Drive Bio, Inc.
He received his undergraduate degree from Brandeis University and an MBA from Bentley University.
Aktive Positionen von Kevin Gillis
| Unternehmen | Position | Beginn |
|---|---|---|
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm focuses on the healthcare. It participates in early stage capital requirements. The firm also acts as lead investor. | Finanzdirektor/CFO | 01.04.2008 |
Ehemalige bekannte Positionen von Kevin Gillis
| Unternehmen | Position | Ende |
|---|---|---|
Warp Drive Bio, Inc.
 Warp Drive Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Focuses on proprietary genomic technology to discover drugs of natural origin | Direktor/Vorstandsmitglied | - |
| THE COCA-COLA COMPANY | Corporate Officer/Principal | - |
Coley Pharmaceutical Group, Inc.
 Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs to treat chronic diseases | Corporate Officer/Principal | - |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | - |
NinePoint Medical, Inc.
 NinePoint Medical, Inc. Medical SpecialtiesHealth Technology Develops and manufactures imaging tool in evaluation of human tissue microstructure | Direktor/Vorstandsmitglied | - |
Ausbildung von Kevin Gillis
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
95
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
The Coca-Cola Co.
 The Coca-Cola Co. Beverages: Non-AlcoholicConsumer Non-Durables Manufactures, wholesales and retails nonalcoholic beverages | Consumer Non-Durables |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Coley Pharmaceutical Group, Inc.
Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs to treat chronic diseases | Health Technology |
NinePoint Medical, Inc.
NinePoint Medical, Inc. Medical SpecialtiesHealth Technology Develops and manufactures imaging tool in evaluation of human tissue microstructure | Health Technology |
Bentley University
 Bentley University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Brandeis University
 Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm focuses on the healthcare. It participates in early stage capital requirements. The firm also acts as lead investor. | Finance |
Warp Drive Bio, Inc.
Warp Drive Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Focuses on proprietary genomic technology to discover drugs of natural origin | Commercial Services |
